U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H21NO
Molecular Weight 243.344
Optical Activity ( + / - )
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MORPHINAN-3-OL, (±)-

SMILES

[H][C@@]12CCCC[C@@]13CCN[C@@H]2CC4=CC=C(O)C=C34

InChI

InChIKey=IYNWSQDZXMGGGI-NUEKZKHPSA-N
InChI=1S/C16H21NO/c18-12-5-4-11-9-15-13-3-1-2-6-16(13,7-8-17-15)14(11)10-12/h4-5,10,13,15,17-18H,1-3,6-9H2/t13-,15+,16+/m0/s1

HIDE SMILES / InChI

Molecular Formula C16H21NO
Molecular Weight 243.344
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

PubMed

PubMed

TitleDatePubMed
Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?
2001 Nov
A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine--application for drug interaction studies assessing potential CYP3A and CYP2D6 inhibition.
2002 Aug 22
Maintenance of liver functions in rat hepatocytes cultured as spheroids in a rotating wall vessel.
2003 Jan-Feb
New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice.
2003 Mar 7
Influence of phenylalanine 120 on cytochrome P450 2D6 catalytic selectivity and regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)-coumarin metabolism.
2004 Dec 1
LC-MS/MS analysis of dextromethorphan metabolism in human saliva and urine to determine CYP2D6 phenotype and individual variability in N-demethylation and glucuronidation.
2004 Dec 25
Effect of methamphetamine on the pharmacokinetics of dextromethorphan and midazolam in rats.
2005 Jul-Sep
Evaluation of dextromethorphan metabolism using hepatocytes from CYP2D6 poor and extensive metabolizers.
2005 Jun
3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.
2005 Mar
Validation of a liquid chromatography-mass spectrometry method to assess the metabolism of dextromethorphan in rat everted gut sacs.
2005 May 5
Selective effects of nitric oxide on the disposition of chlorzoxazone and dextromethorphan in isolated perfused rat livers.
2006 Jul
Neuropsychotoxicity of abused drugs: potential of dextromethorphan and novel neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and neuroprotective effects.
2008 Jan
Concise synthesis of dimemorfan (DF) starting from 3-hydroxymorphinan (3-HM).
2008 Jul
Inhibitory effect of glutamate release from rat cerebrocortical synaptosomes by dextromethorphan and its metabolite 3-hydroxymorphinan.
2009 Jul
A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to in vitro CYP2D6 and CYP3A4 inhibition study.
2009 Nov
Neuropsychotoxic and neuroprotective potentials of dextromethorphan and its analogs.
2011
Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:36:17 GMT 2023
Edited
by admin
on Sat Dec 16 17:36:17 GMT 2023
Record UNII
E4S6LA88PG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MORPHINAN-3-OL, (±)-
Common Name English
(±)-3-HYDROXYMORPHINAN
Common Name English
Code System Code Type Description
WIKIPEDIA
3-Hydroxymorphinan
Created by admin on Sat Dec 16 17:36:17 GMT 2023 , Edited by admin on Sat Dec 16 17:36:17 GMT 2023
PRIMARY
FDA UNII
E4S6LA88PG
Created by admin on Sat Dec 16 17:36:17 GMT 2023 , Edited by admin on Sat Dec 16 17:36:17 GMT 2023
PRIMARY
PUBCHEM
5463854
Created by admin on Sat Dec 16 17:36:17 GMT 2023 , Edited by admin on Sat Dec 16 17:36:17 GMT 2023
PRIMARY
CAS
39131-41-4
Created by admin on Sat Dec 16 17:36:17 GMT 2023 , Edited by admin on Sat Dec 16 17:36:17 GMT 2023
PRIMARY